Granules India Ltd. NSE: GRANULES | BSE: 532482

Strong Performer, Getting Expensive

In 1 Starfolio Basket

Download real time

612.25 -2.55 (-0.41%)

New 52W High today

2.9M

NSE+BSE Volume

NSE 24 Dec, 2025 2:04 PM (IST)

US FDA Approval

Granules India's arm receives US FDA approval for an ADHD drug, with a market size of $172 million See details

Granules Earnings/Conference Calls

Granules earnings concalls and investor presentations

Is Granules India Ltd. worth buying?

868 Votes:

Buy 84.1%

Sell 10.14%

Hold 5.76%

RESEARCH REPORTS

Buy SEE REPORTS >

Accumulate SEE REPORTS >